Trial intelligence / Profile preview

Fenfluramine on Cognition in Healthy Volunteers

NCT05026398Phase 4Completed

Sponsor
University of Oxford
Start
Apr 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Fenfluramine with Placebo (2 arms). Primary endpoints: Change in Go/No-Go Task performance at Day 7, Change in Auditory Verbal Learning Task at Day 7 and 1 more. Started Apr 2021; status: completed.

02

Drugs

fenfluramine

Beyond the preview

Go deeper on NCT05026398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05026398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call